The bill aims to enhance the enforcement of regulations regarding the delivery of 340B prescription drugs by drug manufacturers in Minnesota. It introduces a new subdivision to Minnesota Statutes 2024, section 62J.96, which classifies violations of the provisions related to 340B drugs as unfair or deceptive trade practices. This classification allows the attorney general to enforce these provisions more effectively.

Additionally, the bill removes the expiration date for the current regulations, ensuring that the protections for 340B prescription drugs remain in effect indefinitely. Specifically, it repeals subdivision 3 of section 62J.96, which previously stated that the section would expire on July 1, 2027. This change solidifies the ongoing commitment to maintaining access to affordable medications through the 340B program.

Statutes affected:
Introduction: 62J.96